Phase 2 Lung Cancer Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are willing and able to give informed consent, understand the study, and are able to follow all study procedures to completion.
- People aged between 18 and 70 years old.
- People who have been diagnosed through laboratory testing with non-small cell lung cancer that cannot be removed by surgery and has either spread locally or to other parts of the body.
- People who have at least one tumour that can be measured using standard imaging criteria (known as RECIST v1.1).
- People whose general health and ability to carry out daily activities falls within a certain range, rated as 0 or 1 on a standard scale used by doctors (confirm with trial site).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have cancer that has spread to the brain and is currently active or causing symptoms.
- People who have previously been diagnosed with any other type of cancer.
- People who have a significant build-up of fluid in the abdomen that is causing symptoms, or fluid around the lungs or heart that cannot be controlled or is moderate to severe.
- People who have received any cancer treatment within the 4 weeks before the study treatment would begin.
- People who have cancer-related pain that cannot be controlled.
- People who have serious heart or blood vessel conditions (confirm with trial site for specific conditions).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0518-82342973
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
Determination of Recommended Phase II dose (RP2D); Objective Response Rate (ORR); Incidence and severity of AEs
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.